Effects of Alzheimer's disease severity on activities of daily living with long-term rivastigmine treatment.

被引：0
|
作者：
Anand, R [1 ]
Hartman, R [1 ]
Graham, S [1 ]
机构：
[1] Novartis Pharmaceut Corp, CNS Med Affairs, E Hanover, NJ USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2001年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P446
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [41] Managing expectations in the long-term treatment of Alzheimer's disease
    Gauthier, S
    GERONTOLOGY, 1999, 45 : 33 - 38
  • [42] Long-term effects of rivastigmine in moderately severe Alzheimer's disease - Does early initiation of therapy offer sustained benefits?
    Doraiswamy, PM
    Krishnan, KRR
    Anand, R
    Sohn, H
    Danyluk, J
    Hartman, RD
    Veach, J
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (04): : 705 - 712
  • [43] Predicting dependency in activities of daily living in patients with Alzheimer's disease
    Mangone, CA
    Allegri, RF
    Gabay, P
    Baumann, PD
    DePascale, AM
    Taragano, F
    Litvan, I
    NEUROLOGY, 1996, 46 (02) : 6019 - 6019
  • [44] Neurobiological Correlates of Instrumental Activities of Daily Living in Alzheimer's Disease
    Melrose, Rebecca J.
    Harwood, Dylan G.
    Campa, Olivia
    Mandelkern, Mark A.
    Bussel, Natalya
    Sultzer, David L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A82 - A82
  • [45] Rivastigmine Effects and the Relationships between Executive Function and Cognition, Behavior and Activities of Daily Living in Parkinson's Disease Dementia
    Schmitt, Frederick
    Farlow, Martin
    Olin, Jason
    Meng, Xiangyi
    ANNALS OF NEUROLOGY, 2009, 66 : S46 - S46
  • [46] Effects of neuropsychiatric symptoms of dementia on reductions in activities of daily living in patients with Alzheimer's disease
    Okabe, Kiwamu
    Nagata, Tomoyuki
    Shinagawa, Shunichiro
    Inamura, Keisuke
    Tagai, Kenji
    Nukariya, Kazutaka
    Shigeta, Masahiro
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (06) : 584 - 588
  • [47] Rivastigmine in the treatment of Alzheimer's disease: an update
    Onor, Maria Luisa
    Trevisiol, Marianna
    Aguglia, Eugenio
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01): : 17 - 32
  • [48] Disease stage in Alzheimer disease and treatment effects of rivastigmine
    Kurz, A
    Farlow, M
    Quarg, P
    Spiegel, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 (03): : 123 - 128
  • [49] Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains
    Erkinjuntt, T
    Skoog, I
    Lane, R
    Andrews, C
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (09) : 756 - 760
  • [50] Long-term cognitive trajectory and activities of daily living in healthy aging
    Bezdicek, Ondrej
    Cervenkova, Marketa
    Georgi, Hana
    Schmand, Ben
    Hladka, Adela
    Rulseh, Aaron
    Kopecek, Miloslav
    CLINICAL NEUROPSYCHOLOGIST, 2021, 35 (08) : 1381 - 1397
12345